← Open Payments lookup

CAROL BIVINS: Open Payments

NPI 1154935880 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,181 in 103 payments from 15 companies in 2025. Trend: 2023 $2,391 · 2024 $2,327 · 2025 $2,181

Food & beverage: $2,181
CompanyPaymentsAmount
ABBVIE INC.31$620
Takeda Pharmaceuticals U.S.A., Inc.23$410
GENZYME CORPORATION5$245
Regeneron Healthcare Solutions, Inc.5$158
Aimmune Therapeutics, Inc.9$157
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$139
QOL Medical, LLC5$112
Madrigal Pharmaceuticals4$73
Ipsen Biopharmaceuticals, Inc3$63
Ardelyx, Inc.3$44

Products named: DUPIXENT, RINVOQ, ENTYVIO, XIFAXAN, ZENPEP, Sucraid, EOHILIA, REZDIFFRA.

Industry payments across MO — which companies pay providers there.